regulatory
confidence high
sentiment negative
materiality 0.60
DarioHealth receives Nasdaq delisting notice for bid price below $1.00
DarioHealth Corp.
- Nasdaq notice on Sept 16, 2024: closing bid price below $1.00 for 30 consecutive business days.
- 180-day compliance period granted until March 17, 2025 to regain compliance.
- To cure, bid price must close at $1.00+ for 10 consecutive business days.
- If not compliant, a second 180-day period may be available if other listing standards met.
- Company will monitor bid price and consider options; no assurance of compliance.